US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Dianthus Therapeutics Inc.

81.91

-0.5400-0.65%

Volume:590.57K

Turnover:48.26M

Market Cap:4.14B

PE:-19.49

High:84.55

Open:81.92

Low:80.52

Close:82.45

52wk High:88.02

52wk Low:13.37

Shares:50.54M

Float Shares:45.13M

Volume Ratio:0.52

T/O Rate:1.31%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.2037

EPS(LYR):-4.2037

ROE:-38.38%

ROA:-24.58%

PB:8.39

PE(LYR):-19.49

Loading ...

Overview Company News Filings

Top Midday Gainers

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-Hewlett Packard Enterprise, Dianthus, 3D Systems

BUZZ-Dianthus jumps after nerve disease drug shows faster‑than‑expected response in trial

Dianthus a ‘viable takeout target,’ says TD Cowen

Dianthus rises 26.3%

Dianthus price target raised to $130 from $47 at H.C. Wainwright

Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Myomo (MYO) and Hims & Hers Health (HIMS)

Analysts Are Bullish on Top Healthcare Stocks: Dianthus Therapeutics (DNTH), Lantheus (LNTH)

Dianthus Shares Jump on Early Decision to OK CIDP Trial

Dianthus price target raised to $110 from $63 at Truist

Dianthus Therapeutics FY 2025 net loss rises 91% to USD 162.34 million

Dianthus Therapeutics Highlights Recent Business Achievements, Including Go Decision for Phase 3 Captivate Cidp Trial, and Reports Q4 and FY 2025 Financial Results

THOMSON REUTERS

Dianthus Therapeutics Inc - Independent Dsmb Review Confirms Go Decision; No Related Serious Infections or Adverse Events

THOMSON REUTERS

Dianthus Therapeutics Announces Early Go Decision Following Interim Responder Analysis in Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (Cidp)

THOMSON REUTERS

Dianthus Therapeutics Inc - Maintains 300Mg/2Ml S.c. Q2w Dose; Plans to Remove 600Mg/4Ml S.c. Q2w Arm

THOMSON REUTERS

Dianthus Therapeutics Inc - Expects to Provide Captivate Part B Top-Line Guidance by End of 2026

THOMSON REUTERS

Dianthus Therapeutics to Present Interim Phase 3 CAPTIVATE CIDP Trial Responder Results for Claseprubart

Dianthus price target raised to $200 from $100 at Guggenheim

BRIEF-Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Dianthus Therapeutics Grants 26,000 Inducement Stock Options to New Hires

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/DNTH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DNTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNTH\",,,,,undefined,":{"symbol":"DNTH","market":"US","secType":"STK","nameCN":"Dianthus Therapeutics Inc.","latestPrice":81.91,"timestamp":1774637121064,"preClose":82.45,"halted":0,"volume":590570,"delay":0,"changeRate":-0.006549423893268723,"floatShares":45134300,"shares":50536700,"eps":-4.203707,"marketStatus":"Trading","change":-0.54,"latestTime":"03-27 14:45:25 EDT","open":81.92,"high":84.55,"low":80.52,"amount":48257819.2629,"amplitude":0.048878,"askPrice":82.17,"askSize":160,"bidPrice":81.7,"bidSize":122,"shortable":3,"etf":0,"ttmEps":-4.203707,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774641600000},"marketStatusCode":2,"adr":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":82.45,"preHourTrading":{"tag":"盘前","latestPrice":81.67,"preClose":82.45,"latestTime":"09:29 EDT","volume":1746,"amount":142961.8689,"timestamp":1774618199999,"change":-0.78,"changeRate":-0.00946,"amplitude":0.047301},"postHourTrading":{"tag":"盘后","latestPrice":83.37,"preClose":82.45,"latestTime":"17:23 EDT","volume":7170,"amount":591677.22,"timestamp":1774560205106,"change":0.92,"changeRate":0.011158,"amplitude":0.01128},"volumeRatio":0.517642,"impliedVol":0.5731,"impliedVolPercentile":0.239},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNTH\",,,,,undefined,":{"symbol":"DNTH","floatShares":45134300,"roa":"-24.58%","roe":"-38.38%","lyrEps":-4.203707,"volumeRatio":0.517642,"shares":50536700,"dividePrice":0,"high":84.55,"amplitude":0.048878,"preClose":82.45,"low":80.52,"week52Low":13.365,"pbRate":"8.39","psRate":"2033.13","week52High":88.0202,"institutionHeld":0,"latestPrice":81.91,"committee":-0.134752,"eps":-4.203707,"divideRate":0,"volume":590570,"delay":0,"ttmEps":-4.203707,"open":81.92,"prevYearClose":41.21,"prevWeekClose":77.76,"prevMonthClose":55.19,"prevQuarterClose":41.21,"fiveDayClose":77.76,"twentyDayClose":55.19,"sixtyDayClose":40.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DNTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-09","symbol":"DNTH","fiscalQuarterEnding":"2025/12","expectedEps":-0.98,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1773028800000,"reportTimeType":"pre","actualEps":-1.43},{"market":"US","date":"2025-11-05","symbol":"DNTH","fiscalQuarterEnding":"2025/09","expectedEps":-0.86,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"post","actualEps":-0.97},{"market":"US","date":"2025-08-07","symbol":"DNTH","fiscalQuarterEnding":"2025/06","expectedEps":-0.86,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.88},{"market":"US","date":"2025-05-12","symbol":"DNTH","fiscalQuarterEnding":"2025/03","expectedEps":-0.86,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.82},{"market":"US","date":"2025-03-11","symbol":"DNTH","fiscalQuarterEnding":"2024/12","expectedEps":-0.85,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"post","actualEps":-0.81}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DNTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DNTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":16,"updateTime":1773979200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DNTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DNTH","date":"2026-03-26","current":-19.613641,"percent":0.0033,"low":-27.382523,"twenty":-15.413286,"median":-11.614259,"eighty":-6.081945,"high":-2.378652,"avg":-11.354024,"sd":4.964046,"marketCap":4214719227},"quantilePoints":[{"date":"2023-09-22","current":-6.821887,"twenty":-6.869759,"median":-6.842701,"eighty":-6.807317,"marketCap":194260047},{"date":"2023-09-29","current":-5.576152,"twenty":-6.838538,"median":-5.576152,"eighty":-5.435929,"marketCap":201460812},{"date":"2023-10-06","current":-4.920135,"twenty":-6.800032,"median":-5.4757,"eighty":-5.354747,"marketCap":177759540},{"date":"2023-10-13","current":-4.916034,"twenty":-6.077097,"median":-5.403948,"eighty":-4.942276,"marketCap":177611407},{"date":"2023-10-20","current":-5.11694,"twenty":-5.587632,"median":-5.309646,"eighty":-5.016077,"marketCap":184869921},{"date":"2023-10-27","current":-4.75613,"twenty":-5.576152,"median":-5.262494,"eighty":-4.957036,"marketCap":171834222},{"date":"2023-11-03","current":-4.920135,"twenty":-5.49415,"median":-5.12514,"eighty":-4.920135,"marketCap":177759540},{"date":"2023-11-10","current":-4.678228,"twenty":-5.457249,"median":-5.084139,"eighty":-4.879133,"marketCap":169019695},{"date":"2023-11-17","current":-3.935775,"twenty":-5.444949,"median":-4.957036,"eighty":-4.76023,"marketCap":169663374},{"date":"2023-11-24","current":-4.021709,"twenty":-5.412148,"median":-4.920135,"eighty":-4.674948,"marketCap":173367815},{"date":"2023-12-01","current":-3.842966,"twenty":-5.377707,"median":-4.920135,"eighty":-3.993522,"marketCap":165662579},{"date":"2023-12-08","current":-3.640162,"twenty":-5.338346,"median":-4.907834,"eighty":-3.949524,"marketCap":156920099},{"date":"2023-12-15","current":-2.684576,"twenty":-5.297345,"median":-4.846332,"eighty":-3.884902,"marketCap":115726721},{"date":"2023-12-22","current":-3.007688,"twenty":-5.267824,"median":-4.788931,"eighty":-3.85534,"marketCap":129655417},{"date":"2023-12-29","current":-3.482043,"twenty":-5.235843,"median":-4.75818,"eighty":-3.842966,"marketCap":150103929},{"date":"2024-01-05","current":-4.482315,"twenty":-5.235843,"median":-4.715129,"eighty":-3.861528,"marketCap":193223616},{"date":"2024-01-12","current":-4.05952,"twenty":-5.169421,"median":-4.670027,"eighty":-3.873902,"marketCap":174997769},{"date":"2024-01-19","current":-3.952961,"twenty":-5.12186,"median":-4.521845,"eighty":-3.879402,"marketCap":170404263},{"date":"2024-01-26","current":-6.135656,"twenty":-5.267824,"median":-4.661827,"eighty":-3.893152,"marketCap":264495873},{"date":"2024-02-02","current":-14.091886,"twenty":-5.428549,"median":-4.735629,"eighty":-3.901401,"marketCap":607473021},{"date":"2024-02-09","current":-15.77856,"twenty":-5.593373,"median":-4.788931,"eighty":-3.913775,"marketCap":680182147},{"date":"2024-02-16","current":-16.247836,"twenty":-6.141843,"median":-4.875033,"eighty":-3.933712,"marketCap":700411702},{"date":"2024-02-23","current":-16.322648,"twenty":-6.585949,"median":-4.911934,"eighty":-3.935775,"marketCap":703636704},{"date":"2024-03-01","current":-16.832731,"twenty":-6.855189,"median":-4.920135,"eighty":-3.939212,"marketCap":725625351},{"date":"2024-03-08","current":-17.220393,"twenty":-14.108208,"median":-4.920135,"eighty":-3.952961,"marketCap":742336722},{"date":"2024-03-15","current":-18.274564,"twenty":-15.869694,"median":-5.055438,"eighty":-3.952961,"marketCap":787779926},{"date":"2024-03-22","current":-19.002283,"twenty":-16.27504,"median":-5.103895,"eighty":-3.958461,"marketCap":819150396},{"date":"2024-03-28","current":-20.617859,"twenty":-16.390659,"median":-5.12104,"eighty":-3.98046,"marketCap":898010856},{"date":"2024-04-05","current":-16.662734,"twenty":-16.662734,"median":-5.235843,"eighty":-3.987335,"marketCap":725745374},{"date":"2024-04-12","current":-16.777278,"twenty":-16.777278,"median":-5.350646,"eighty":-3.990772,"marketCap":730734324},{"date":"2024-04-19","current":-15.922581,"twenty":-16.832731,"median":-5.444949,"eighty":-3.99421,"marketCap":693508032},{"date":"2024-04-26","current":-14.143673,"twenty":-16.777278,"median":-5.535151,"eighty":-4.021709,"marketCap":616027659},{"date":"2024-05-03","current":-16.178636,"twenty":-16.662734,"median":-5.637242,"eighty":-4.021709,"marketCap":704660510},{"date":"2024-05-10","current":-14.570862,"twenty":-16.662734,"median":-6.140812,"eighty":-4.049207,"marketCap":731661246},{"date":"2024-05-17","current":-15.342363,"twenty":-16.621896,"median":-6.530951,"eighty":-4.05952,"marketCap":770401432},{"date":"2024-05-24","current":-12.724299,"twenty":-16.45867,"median":-6.737265,"eighty":-4.100768,"marketCap":638937940},{"date":"2024-05-31","current":-12.098897,"twenty":-16.404261,"median":-6.842701,"eighty":-4.106268,"marketCap":607534008},{"date":"2024-06-07","current":-12.233329,"twenty":-16.390659,"median":-12.098897,"eighty":-4.121392,"marketCap":614284386},{"date":"2024-06-14","current":-15.75779,"twenty":-16.354335,"median":-12.233329,"eighty":-4.176389,"marketCap":791261684},{"date":"2024-06-21","current":-15.114854,"twenty":-16.327131,"median":-12.630781,"eighty":-4.296009,"marketCap":758977268},{"date":"2024-06-28","current":-14.565435,"twenty":-16.324142,"median":-12.706764,"eighty":-4.381256,"marketCap":731388767},{"date":"2024-07-05","current":-15.459702,"twenty":-16.325636,"median":-12.794437,"eighty":-4.452753,"marketCap":776293455},{"date":"2024-07-12","current":-16.932611,"twenty":-16.417863,"median":-13.066224,"eighty":-4.47819,"marketCap":850254116},{"date":"2024-07-15","current":-16.920921,"twenty":-16.466954,"median":-13.180199,"eighty":-4.480252,"marketCap":849667127},{"date":"2024-08-02","current":-16.371502,"twenty":-16.45867,"median":-13.180199,"eighty":-4.482315,"marketCap":822078626},{"date":"2024-08-09","current":-13.845994,"twenty":-16.50009,"median":-13.738229,"eighty":-4.561374,"marketCap":784804801},{"date":"2024-08-16","current":-15.438194,"twenty":-16.45867,"median":-13.792112,"eighty":-4.661827,"marketCap":875052279},{"date":"2024-08-23","current":-14.304023,"twenty":-16.390659,"median":-14.112289,"eighty":-4.678228,"marketCap":810766318},{"date":"2024-08-30","current":-14.899592,"twenty":-16.390659,"median":-14.219338,"eighty":-4.715129,"marketCap":844523786},{"date":"2024-09-06","current":-14.490462,"twenty":-16.375333,"median":-14.311791,"eighty":-4.74793,"marketCap":821333873},{"date":"2024-09-13","current":-14.402421,"twenty":-16.338396,"median":-14.319559,"eighty":-4.75941,"marketCap":816343639},{"date":"2024-09-20","current":-14.552608,"twenty":-16.324142,"median":-14.311791,"eighty":-4.783191,"marketCap":824856392},{"date":"2024-09-27","current":-13.993291,"twenty":-16.306326,"median":-14.304023,"eighty":-4.815172,"marketCap":793153726},{"date":"2024-10-04","current":-14.221161,"twenty":-16.285922,"median":-14.291076,"eighty":-4.861093,"marketCap":806069627},{"date":"2024-10-11","current":-14.672555,"twenty":-16.269355,"median":-14.319559,"eighty":-4.877493,"marketCap":831655088},{"date":"2024-10-18","current":-14.522306,"twenty":-16.254626,"median":-14.311791,"eighty":-4.902094,"marketCap":823138846},{"date":"2024-10-25","current":-14.475677,"twenty":-16.248614,"median":-14.360865,"eighty":-4.914394,"marketCap":820495874},{"date":"2024-10-31","current":-14.486039,"twenty":-16.239675,"median":-14.366036,"eighty":-4.918495,"marketCap":821083201},{"date":"2024-11-08","current":-13.087312,"twenty":-16.213004,"median":-14.381745,"eighty":-4.920135,"marketCap":878053924},{"date":"2024-11-15","current":-11.244659,"twenty":-16.189942,"median":-14.360865,"eighty":-4.920135,"marketCap":754426637},{"date":"2024-11-22","current":-8.941908,"twenty":-16.180782,"median":-14.311791,"eighty":-4.920135,"marketCap":599930480},{"date":"2024-11-29","current":-10.582949,"twenty":-16.17095,"median":-14.273283,"eighty":-4.920135,"marketCap":710031190},{"date":"2024-12-06","current":-10.437372,"twenty":-16.142849,"median":-14.241876,"eighty":-4.934895,"marketCap":700264191},{"date":"2024-12-13","current":-10.36679,"twenty":-16.097823,"median":-14.188265,"eighty":-4.996397,"marketCap":695528677},{"date":"2024-12-20","current":-10.163866,"twenty":-16.05809,"median":-14.112289,"eighty":-5.061998,"marketCap":681914073},{"date":"2024-12-27","current":-10.14622,"twenty":-16.019613,"median":-14.091886,"eighty":-5.076759,"marketCap":680730195},{"date":"2025-01-03","current":-10.234448,"twenty":-15.922581,"median":-13.957579,"eighty":-5.096439,"marketCap":686649588},{"date":"2025-01-10","current":-11.284361,"twenty":-15.89482,"median":-13.822388,"eighty":-5.108369,"marketCap":757090364},{"date":"2025-01-17","current":-8.474299,"twenty":-15.887478,"median":-13.728741,"eighty":-5.115822,"marketCap":568557697},{"date":"2025-01-24","current":-9.828599,"twenty":-15.834329,"median":-13.708453,"eighty":-5.12186,"marketCap":659420380},{"date":"2025-01-31","current":-9.603618,"twenty":-15.788231,"median":-13.553088,"eighty":-5.191562,"marketCap":644325928},{"date":"2025-02-07","current":-10.128574,"twenty":-15.779567,"median":-13.462457,"eighty":-5.235843,"marketCap":679546316},{"date":"2025-02-14","current":-10.644708,"twenty":-15.766098,"median":-13.180199,"eighty":-5.267824,"marketCap":714174765},{"date":"2025-02-21","current":-10.455018,"twenty":-15.745542,"median":-13.087312,"eighty":-5.305545,"marketCap":701448070},{"date":"2025-02-28","current":-9.285997,"twenty":-15.702913,"median":-12.81575,"eighty":-5.346546,"marketCap":623016113},{"date":"2025-03-07","current":-10.375613,"twenty":-15.663831,"median":-12.724299,"eighty":-5.384267,"marketCap":696120616},{"date":"2025-03-14","current":-8.045567,"twenty":-15.60664,"median":-12.588406,"eighty":-5.420348,"marketCap":683623809},{"date":"2025-03-21","current":-7.727979,"twenty":-15.500032,"median":-12.233329,"eighty":-5.449869,"marketCap":656638658},{"date":"2025-03-28","current":-7.512473,"twenty":-15.459702,"median":-12.013661,"eighty":-5.472009,"marketCap":638327306},{"date":"2025-04-04","current":-6.416037,"twenty":-15.451099,"median":-11.624039,"eighty":-5.526951,"marketCap":545164287},{"date":"2025-04-11","current":-5.898066,"twenty":-15.431979,"median":-11.290978,"eighty":-5.587632,"marketCap":501152792},{"date":"2025-04-17","current":-7.175981,"twenty":-15.413286,"median":-11.262304,"eighty":-5.60754,"marketCap":609735897},{"date":"2025-04-25","current":-8.026663,"twenty":-15.369114,"median":-11.0285,"eighty":-5.622077,"marketCap":682017550},{"date":"2025-05-02","current":-8.204554,"twenty":-15.321347,"median":-10.898364,"eighty":-5.689407,"marketCap":697132746},{"date":"2025-05-09","current":-7.796217,"twenty":-15.230244,"median":-10.759405,"eighty":-5.898822,"marketCap":662436738},{"date":"2025-05-16","current":-5.986178,"twenty":-15.201008,"median":-10.704262,"eighty":-5.916298,"marketCap":602999662},{"date":"2025-05-23","current":-5.861665,"twenty":-15.193619,"median":-10.675588,"eighty":-5.916298,"marketCap":590457269},{"date":"2025-05-30","current":-5.698841,"twenty":-15.181369,"median":-10.600594,"eighty":-5.861665,"marketCap":574055678},{"date":"2025-06-06","current":-5.92871,"twenty":-15.126544,"median":-10.582949,"eighty":-5.698841,"marketCap":597210865},{"date":"2025-06-13","current":-6.15858,"twenty":-15.114854,"median":-10.503543,"eighty":-5.724382,"marketCap":620366052},{"date":"2025-06-20","current":-5.567944,"twenty":-15.086799,"median":-10.455018,"eighty":-5.687986,"marketCap":560870086},{"date":"2025-06-27","current":-5.788235,"twenty":-15.056571,"median":-10.424138,"eighty":-5.643102,"marketCap":583060473},{"date":"2025-07-03","current":-6.018104,"twenty":-15.025316,"median":-10.371201,"eighty":-5.641637,"marketCap":606215660},{"date":"2025-07-11","current":-6.580007,"twenty":-15.002134,"median":-10.30503,"eighty":-5.677131,"marketCap":662817229},{"date":"2025-07-18","current":-6.496998,"twenty":-14.98745,"median":-10.28959,"eighty":-5.714166,"marketCap":654455633},{"date":"2025-07-25","current":-6.956737,"twenty":-14.950568,"median":-10.234448,"eighty":-5.730129,"marketCap":700766007},{"date":"2025-08-01","current":-6.599162,"twenty":-14.912021,"median":-10.163866,"eighty":-5.73396,"marketCap":664746827},{"date":"2025-08-08","current":-6.113883,"twenty":-14.897039,"median":-10.14622,"eighty":-5.764609,"marketCap":615863655},{"date":"2025-08-15","current":-5.680098,"twenty":-14.891675,"median":-10.102106,"eighty":-5.714166,"marketCap":651813986},{"date":"2025-08-22","current":-6.633794,"twenty":-14.884329,"median":-10.031524,"eighty":-5.730129,"marketCap":761254359},{"date":"2025-08-29","current":-6.959172,"twenty":-14.857999,"median":-9.84404,"eighty":-5.73396,"marketCap":798592839},{"date":"2025-09-05","current":-6.917097,"twenty":-14.83641,"median":-9.826394,"eighty":-5.754393,"marketCap":793764587},{"date":"2025-09-12","current":-10.61968,"twenty":-14.806372,"median":-9.828599,"eighty":-5.786319,"marketCap":1218650741},{"date":"2025-09-19","current":-13.100588,"twenty":-14.770844,"median":-9.916203,"eighty":-5.789512,"marketCap":1503344826},{"date":"2025-09-26","current":-12.079369,"twenty":-14.762402,"median":-10.031524,"eighty":-5.797813,"marketCap":1386155868},{"date":"2025-10-03","current":-12.446738,"twenty":-14.758601,"median":-10.102106,"eighty":-5.811222,"marketCap":1428312952},{"date":"2025-10-10","current":-11.711999,"twenty":-14.750427,"median":-10.14622,"eighty":-5.817199,"marketCap":1343998784},{"date":"2025-10-17","current":-12.133294,"twenty":-14.726754,"median":-10.163866,"eighty":-5.821144,"marketCap":1392344064},{"date":"2025-10-24","current":-11.213186,"twenty":-14.705712,"median":-10.234448,"eighty":-5.826546,"marketCap":1286757972},{"date":"2025-10-31","current":-11.371593,"twenty":-14.704884,"median":-10.28959,"eighty":-5.834208,"marketCap":1304935797},{"date":"2025-11-07","current":-11.48051,"twenty":-14.703303,"median":-10.30503,"eighty":-5.84678,"marketCap":1450505040},{"date":"2025-11-14","current":-12.047161,"twenty":-14.690699,"median":-10.355761,"eighty":-5.85115,"marketCap":1522098532},{"date":"2025-11-21","current":-13.706615,"twenty":-14.666007,"median":-10.410904,"eighty":-5.857834,"marketCap":1731762245},{"date":"2025-11-28","current":-14.924905,"twenty":-14.703472,"median":-10.441784,"eighty":-5.865182,"marketCap":1885687139},{"date":"2025-12-05","current":-15.172635,"twenty":-14.705712,"median":-10.501337,"eighty":-5.879885,"marketCap":1916986630},{"date":"2025-12-12","current":-14.127417,"twenty":-14.759182,"median":-10.582949,"eighty":-5.885547,"marketCap":1784928504},{"date":"2025-12-19","current":-14.16814,"twenty":-14.753642,"median":-10.600594,"eighty":-5.898822,"marketCap":1790073626},{"date":"2025-12-26","current":-14.643239,"twenty":-14.756857,"median":-10.62529,"eighty":-5.901847,"marketCap":1850100047},{"date":"2026-01-02","current":-13.984887,"twenty":-14.743997,"median":-10.660148,"eighty":-5.923337,"marketCap":1766920578},{"date":"2026-01-09","current":-12.936275,"twenty":-14.712726,"median":-10.702056,"eighty":-5.944035,"marketCap":1634433691},{"date":"2026-01-16","current":-14.931692,"twenty":-14.757438,"median":-10.748376,"eighty":-5.968854,"marketCap":1886544660},{"date":"2026-01-23","current":-17.904456,"twenty":-14.780844,"median":-10.845427,"eighty":-5.981347,"marketCap":2262138551},{"date":"2026-01-30","current":-18.10807,"twenty":-14.824694,"median":-10.944683,"eighty":-5.986178,"marketCap":2287864160},{"date":"2026-02-06","current":-15.93519,"twenty":-14.884329,"median":-11.08833,"eighty":-5.986178,"marketCap":2013331532},{"date":"2026-02-13","current":-16.243083,"twenty":-14.922869,"median":-11.213186,"eighty":-6.003418,"marketCap":2052232313},{"date":"2026-02-20","current":-17.009395,"twenty":-14.931281,"median":-11.273853,"eighty":-6.016188,"marketCap":2149052034},{"date":"2026-02-27","current":-18.169127,"twenty":-14.990963,"median":-11.290903,"eighty":-6.018104,"marketCap":2295578309},{"date":"2026-03-06","current":-21.015429,"twenty":-15.068178,"median":-11.337298,"eighty":-6.018104,"marketCap":2655194418},{"date":"2026-03-13","current":-25.621671,"twenty":-15.177875,"median":-11.385074,"eighty":-6.024489,"marketCap":4159345176},{"date":"2026-03-20","current":-26.089965,"twenty":-15.231785,"median":-11.48051,"eighty":-6.051946,"marketCap":4235366640},{"date":"2026-03-26","current":-25.962776,"twenty":-15.413286,"median":-11.614259,"eighty":-6.081945,"marketCap":4214719227}],"updateTime":1774606407903},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DNTH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618894679","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2618894679","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618894679?lang=en_us&edition=fundamental","pubTime":"2026-03-10 02:42","pubTimestamp":1773081760,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics  said Monday it has struck a deal to sell shares and pre-funded warrants to investors, including Venrock Healthcare Capital Partners and Commodore Capital, to raise about $160 million. It expects to close the deal March 11.Shares soared 46% as intraday trading volume surged to over 36.4 million from a daily average of about 676,000.Dianthus Therapeutics  said early Go decision was reached in phase 3 trial of claseprubart in chronic inflammatory demyelinating polyneuropathy after 20 confirmed responders were achieved with less than 40 planned participants completing open-label part A of the trial. The firm also reported Q4 results.Shares jumped 18% as intraday trading volume climbed to more than 3.2 million from a daily average of about 795,000.Xenon Pharmaceuticals  reported \"positive\" topline results from its phase 3 study of azetukalner in focal onset seizures.Shares soared 46% as intraday trading volume jumped to over 9.5 million from a daily average of roughly ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RLMD","XENE","BK4007","BK4139","DNTH"],"gpt_icon":0},{"id":"2618675790","title":"BUZZ-U.S. STOCKS ON THE MOVE-Hewlett Packard Enterprise, Dianthus, 3D Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2618675790","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618675790?lang=en_us&edition=fundamental","pubTime":"2026-03-10 01:46","pubTimestamp":1773078415,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Hewlett Packard Enterprise, Dianthus, 3D SystemsWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning New","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL6N3ZX0NC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2381873111.SGD","LU0654597011.USD","LU1069347547.HKD","LU1201861249.SGD","LU1670628061.USD","LU2357305700.SGD","LU0289961442.SGD","IE00BJTD4V19.USD","SG9999015358.SGD","BK4108","LU0048573561.USD","IE0009354923.USD","BK4207","LU2456880835.USD","LU2361044949.HKD","IE00BN0W2W23.USD","LU0985481810.HKD","IE0031619046.USD","LU0265550359.USD","LU1066051498.USD","LU0868494708.USD","LU2361045086.USD","LU1814569148.SGD","BK4500","LU1244550494.USD","LU0289739343.SGD","LU2498475776.HKD","LU0234570918.USD","IE000M9KFDE8.USD","IE00BN0W2T93.GBP","LU2764263203.CNY","GB00BDT5M118.USD","DDD","IE00BMPRXN33.USD","LU2272731600.USD","LU0788109394.HKD","LU0130517989.USD","IE00B894F039.SGD","LU2237443465.HKD","LU1023059493.AUD","LU0256863902.USD","LU2552382058.USD","LU1150488218.USD","NWMX","BK4597","LU0203345920.USD","IE00B19Z9P08.USD","LU0882574139.USD","LU0788108826.HKD","LU1582987597.SGD","LU1621767737.EUR","LU1093756168.USD","LU0345781412.USD","LU2237443382.USD","BK4504","BK4179","LU0630314457.HKD","BK4081","LU2362541513.USD","LU0310800379.SGD","LU0266512127.USD","LU2506951792.HKD","SG9999002521.SGD","IE00B29SXK94.USD","LU0323240290.USD","LU1244550221.USD","LU0175139822.USD","LU0130103400.USD","LU1989763690.USD","LU2242649171.HKD","LU2746668974.SGD","IE00B3S45H60.SGD","LU0070302665.USD","LU0162691827.USD","DNTH","LU0098860793.USD","LU1363072403.SGD","LU1861214812.USD","LU0942090050.USD","VRTL","LU0205193047.USD","SG9999013999.USD","LU0205194284.USD","LU1280957306.USD","BK4196","LU1894683264.USD","IE00B0JY6N72.USD","LU2491050071.SGD","LU1145028129.USD","LU1261432733.SGD","LU2125154778.USD","LU1778281490.HKD","LU2089985449.USD","BK4216","LU0061474960.USD","IE00BMPRXQ63.HKD","LU0278409577.USD","LU2213496289.HKD","LU0980610538.SGD","LU0106261372.USD","SG9999002232.USD","LU2720916845.USD","LU2211815571.USD","LU1720051017.SGD","LU0006061336.USD","LU1201861165.SGD","LU2756315664.SGD","LU1064131342.USD","LU2473716301.USD","LU0368265418.SGD","LU1804176565.USD","LU0054578231.USD","LU2048586759.USD","LU0321505868.SGD","LU2087621335.USD","LU0106261612.USD","LU0889566641.SGD","IE00BN0W2V16.EUR","XOMX","LU0215105999.USD","BK4520","IE00B29SXL02.USD","LU0648001328.SGD","LU0985489474.SGD","LU0345769128.USD","LU1093756325.SGD","IE00BKDWB100.SGD","BK4213","LU1551013342.USD","SG9999001176.SGD","HMYY","LU2023250330.USD","LU2462611646.USD","LU2125909593.SGD","BK4515","LU1223083913.SGD","LU1074936037.SGD","IE0034235188.USD","LU0433182093.SGD","LU0029864427.USD","LU2756315318.SGD","LU0417517546.SGD","LU2433249047.HKD","LU0498741114.HKD","LU0203347892.USD","LU2764263039.SGD","LU0971096721.USD","LU0496367417.USD","LU0128525929.USD","IE0001KFT4U8.USD","LU0878866978.SGD","LU0708994859.HKD","LU2125909916.SGD","LU1267930227.SGD","LU0823414551.USD","XOMO","LU0053666078.USD","HIMZ","BK4533","LU2384288077.EUR","BK4017","IE00BJLML261.HKD","LU1988902786.USD","BK4546","LU0053671581.USD","LU0075056555.USD","LU2125154935.USD","LU1585245621.USD","COHX","LU2505996681.GBP","JPMO","IE00BZ1G4Q59.USD","LU1914381329.SGD","LU0496365809.HKD","LU0211327993.USD","LU2294711713.HKD","IE00B19Z4B17.USD","BK4148","IE00B66KJ199.SGD","LU0385154629.USD","LU1506573853.SGD","LU0256331488.USD","LU2491049909.HKD","BK4606","BK4541","LU1119994496.HKD","LU0323591593.USD","LU2462157665.USD","LU2322448957.HKD","IE0034235295.USD","LU2023250504.SGD","LU2602419157.SGD","LU0267386448.USD","LU2362540622.SGD","LU1023059063.AUD","IE00BYXW3230.USD","SGXZ57979304.SGD","LU0048584097.USD","LU1732799900.SGD","LU1496350171.SGD","LU1670627923.USD","LU0077335932.USD","IE0034235303.USD","LU0368265764.SGD","LU1223082196.USD","LU1035773651.USD","LU0300736492.USD","LU0130518102.USD","LU1861220033.SGD","LU1917777945.USD","BK4113","LU1430597077.USD","BK4210","IE00BWXC8680.SGD","LU1732800096.USD","LU2129689431.USD","LU1629891620.HKD","LU0330918003.SGD","LU2264538146.SGD","LU0154236417.USD","LU2065731478.USD","LU0787776722.HKD","LU0795875169.SGD","LU1162221912.USD","IE00BZ199S13.USD","LU0128525689.USD","LU0820561818.USD","LU1621768206.USD","LU0345770993.USD","LU0289960550.SGD","LU0957791311.USD","LU0265550946.USD","BK4568","BK4089","BK4157","SG9999015341.SGD","LU1791807156.HKD","LU0052756011.USD","LU0912757837.SGD","LU1894683348.USD","LU2237438978.USD","SG9999014567.USD","LU0211326839.USD","IE00BSNM7G36.USD","LU0300736062.USD","LU1366192091.USD","IE00B19Z3B42.SGD","LU1923622291.USD","LU2211817866.USD","LU2417539215.USD","LU0868494617.USD","LU1548497426.USD","LU0122379950.USD","LU1992135399.USD","BK4161","IE00BLSP4239.USD","LU1223082519.USD","LU1621768115.EUR","LU0345780521.USD","IE00BD6J9T35.USD","LU1839511570.USD","LU1674673691.USD","LU2361044865.SGD","LU2746668461.USD","LU0251131958.USD","BK4559","BK4532","IE00BKVL7J92.USD","LU1674673428.USD","LU1582986359.USD","SATG","HIYY","LU0456854461.SGD","LU0310799852.SGD","IE00BBT3K403.USD","SG9999002224.SGD","LU0251132253.USD","BK4585","LU0274383776.USD","LU1244550577.SGD","LU2237443978.SGD","LU0345770308.USD","LU0312595415.SGD","BK4100","LU0211331839.USD","LU2592432038.USD","BK4543","IE00B1XK9C88.USD","IE00BFXG1179.USD","LU0310800965.SGD","LU0466842654.USD","LU0456855351.SGD","BK4224","LU1582987324.SGD","LU2237443895.HKD","BK4171","LU0149725797.USD","LU0345769631.USD","LU0058720904.USD","AALG","LU1880398471.USD","LITX","LU0306806265.USD","LU1880398554.USD","SGXZ99366536.SGD","LU1989763427.SGD","LU1496350502.SGD","BK4516","LU0786609619.USD","LU0477156797.USD","LU2764262908.HKD","SG9999014542.SGD","LU0964807845.USD","LU0314106906.USD","SG9999001176.USD","LU0006306889.USD","BK4599","LU2249611893.SGD","LU1267930490.SGD","LU2463526074.USD","LU0345780281.USD","BK4592","LU0742534661.SGD","LU1929549753.HKD","BK4090","IE00BFMHRM44.USD","BK4534","LU2505996509.AUD","SG9999004303.SGD","LU0289739699.SGD","LU0788109121.HKD","BK4501","LU1267930813.SGD","BK4127","BK4149","BK4567","LU2461242641.AUD","LU1668664300.SGD","BK4551","LU2347655156.SGD","SG9999011175.SGD","LU2552382132.HKD","LU0471298777.SGD","IE00B2Q91V27.USD","IE00B7SZL793.SGD","IE00BZ9MQY76.HKD","LU0320765646.SGD","HPE","LU0170899867.USD","BK4563","LU0068578508.USD","IE00B7SZLL34.SGD","IE00B1BXHZ80.USD","LU1116320737.USD","LU1720051108.HKD","LU2133065610.SGD","HIMY","LU0211328371.USD","BK4201","SGXZ23171101.USD","IE00BLSP4452.SGD","LU0943347566.SGD","IE00BMPRXR70.SGD","LU2290526834.HKD","LU0240877869.USD","BK4152","IE00B775SV38.USD","IE0002270589.USD","IE00BJTD4N35.SGD","SGXZ81514606.USD","IE00BDRTCR15.USD","IE00B3CCJ963.GBP","LU0122376428.USD","LU1974910355.USD","LU1489326972.SGD","LU2237443549.SGD","IE00BGHQF524.EUR","LU2322448791.USD","BK4547","LU1582986433.USD","IE00BDCRKT87.USD","LU1116320901.HKD","LU0106831901.USD","LU1551013425.SGD","LU1718418525.SGD","LU0266512473.USD","LU0477156953.USD","LU0256863811.USD","LU1883839398.USD","LU0238689110.USD","BK4139","LU0012050646.USD","LU1621767810.EUR","LU2236285917.USD","BK4566","NEMG","LU1267930573.SGD","LU0689472784.USD","LU2362541273.HKD","LU1057294990.SGD","LU0724618789.USD","LU2430703251.USD","BK4020","BK4553","LU1084165304.USD","LU0321505439.SGD","LU0612318971.USD","LU2272731865.HKD","LU0225771236.USD","SG9999003800.SGD","LU0211326755.USD","IE0004445239.USD","LU0072461881.USD","LU1861219969.SGD","LU2023250843.SGD","BK4588","LU0792757196.USD","LU1992135472.HKD","LU2357125470.USD","LU2106854487.HKD","LU0820562030.AUD","LU2430703095.HKD","LU1861215975.USD","SG9999014575.USD","LU2543165471.USD","BK4170","LU1883866441.USD","LU2360107168.USD","BK4096","IE00B19Z3581.USD","LU0345780950.USD","LU2054465674.USD","LU2129689605.HKD","LU1066053197.SGD","LU2491050154.USD","LU1032466523.USD","LU0648000940.SGD","LU1923622614.USD","IE00BN8TJ469.HKD","LU0208291251.USD","LU0640476718.USD","BK4505","LU2129689514.USD","LU0320765489.SGD","LU0070217475.USD","LU0251142724.SGD","LU0683600562.USD","LU2430703178.SGD","LU0234572021.USD","SG9999014559.SGD","IE00B19Z9Z06.USD","LU1150488135.SGD","XOMZ","LU0225284248.USD","SG9999001143.SGD","LU1430594728.SGD","LU0795875086.SGD","LU0820561909.HKD","BK4007","LU0130102774.USD","LU2272731782.SGD","LU0823414478.USD","BK4581","LU0511384066.AUD","SGXZ51526630.SGD","LU0240878834.USD","LU2265009873.SGD","BK4008","LU2931357623.SGD","BK4570","LU0498741890.SGD","LU2125909759.SGD","LU0348723411.USD","LU2552382215.SGD","LU0612318385.USD","IE00BHPRN162.USD","LU2125909247.SGD","LU2360032135.SGD","SG9999001440.SGD","LU0976567544.SGD","LU1815333072.USD","LU0306807586.USD","BK4550","LU0055631609.USD","LU2237443622.USD"],"gpt_icon":0},{"id":"2618673651","title":"BUZZ-Dianthus jumps after nerve disease drug shows faster‑than‑expected response in trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2618673651","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618673651?lang=en_us&edition=fundamental","pubTime":"2026-03-10 00:53","pubTimestamp":1773075216,"startTime":"0","endTime":"0","summary":"BUZZ-Dianthus jumps after nerve disease drug shows fasterthanexpected response in trial** Shares of Dianthus Therapeutics DNTH.O rise 26% to over four-year high of $82.27** Co says it reached an early \"go\" decision on its experimental drug for a rare nerve disease ahead of schedule in a latestage trial** A \"go\" decision means the trial has shown enough early success for the company to move forward to the next stage of the trial** DNTH is testing the drug, claseprubart, in patients with chronic inflammatory demyelinating polyneuropathy, a rare autoimmune disease where the body attacks the protective coating around nerves, causing weakness, numbness, and loss of balance** The company hit its goal early after 20 patients responded to the drug before all 40 had completed the first part of the trial** The \"decision comes ahead-of-schedule and beats our expectations,\" says Cantor analysts', calling it a \"clinical de-risking event\" that supports a potential drug approval filing** In 2025, DNT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL4N3ZX1P1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2618167849","title":"Dianthus a ‘viable takeout target,’ says TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2618167849","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618167849?lang=en_us&edition=fundamental","pubTime":"2026-03-10 00:10","pubTimestamp":1773072632,"startTime":"0","endTime":"0","summary":"TD Cowen notes that Dianthus (DNTH) has announced an earlier than anticipated “Go” decision for its Phase 3 CAPTIVATE study of claseprubart in CIDP...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-a-viable-takeout-target-says-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-a-viable-takeout-target-says-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","BK4127","BK4207","COWN","TD","DNTH","BK4139","BK4585"],"gpt_icon":0},{"id":"2618678405","title":"Dianthus rises 26.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618678405","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618678405?lang=en_us&edition=fundamental","pubTime":"2026-03-10 00:07","pubTimestamp":1773072430,"startTime":"0","endTime":"0","summary":"Dianthus (DNTH) is up 26.3%, or $17.15 to $82.35. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-rises-26-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-rises-26-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2618678424","title":"Dianthus price target raised to $130 from $47 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2618678424","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618678424?lang=en_us&edition=fundamental","pubTime":"2026-03-10 00:05","pubTimestamp":1773072317,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Swayampakula Ramakanth raised the firm’s price target on Dianthus (DNTH) to $130 from $47 and keeps a Buy rating on the sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-price-target-raised-to-130-from-47-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-price-target-raised-to-130-from-47-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2618627402","title":"Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Myomo (MYO) and Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618627402","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618627402?lang=en_us&edition=fundamental","pubTime":"2026-03-09 22:50","pubTimestamp":1773067811,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Dianthus Therapeutics (DNTH – Research Report), My...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dianthus-therapeutics-dnth-myomo-myo-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dianthus-therapeutics-dnth-myomo-myo-and-hims-hers-health-hims-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HMYY","BK4581","BK4137","HIMS","HIMY","XBI","LU0128526141.USD","MYO","LU0029874061.USD","BK4196","HIMZ","BK4082","DNTH","HIYY","BK4588","BK4139","BK4585","LABU"],"gpt_icon":0},{"id":"2618302629","title":"Analysts Are Bullish on Top Healthcare Stocks: Dianthus Therapeutics (DNTH), Lantheus (LNTH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618302629","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618302629?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:50","pubTimestamp":1773060650,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dianthus Therapeutics (DNTH – Research Report), Lant...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-dianthus-therapeutics-dnth-lantheus-lnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-dianthus-therapeutics-dnth-lantheus-lnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","DNTH","LU0128526141.USD","XBI","LABU","BK4588","LU0029874061.USD","BK4139","BK4198","BLSG","BLSX","LNTH","BK4585","BK4112","BK4137"],"gpt_icon":0},{"id":"2618626543","title":"Dianthus Shares Jump on Early Decision to OK CIDP Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2618626543","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618626543?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:35","pubTimestamp":1773059700,"startTime":"0","endTime":"0","summary":"Shares of Dianthus Therapeutics rose after the company reached an early decision to move ahead with its phase 3 trial for Chronic Inflammatory Demyelinating Polyneuropathy, an autoimmune disorder.The stock jumped 23% to $80.01 in premarket trading after more than doubling over the past 12 months through Friday's close.The company said it reached the decision after achieving a greater than 50% response rate for part A of the trial. The company will provide part B top-line guidance by the end of the year.Dianthus also said its phase three Generalized Myasthenia Gravis trial will begin in the middle of this year, with top-line results expected in the second half of 2028.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Dianthus Shares Jump on Early Decision to OK CIDP Trial","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2618623622","title":"Dianthus price target raised to $110 from $63 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2618623622","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618623622?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:39","pubTimestamp":1773056362,"startTime":"0","endTime":"0","summary":"Truist raised the firm’s price target on Dianthus (DNTH) to $110 from $63 and keeps a Buy rating on the shares. The firm is citing the company havi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-price-target-raised-to-110-from-63-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-price-target-raised-to-110-from-63-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2618640703","title":"Dianthus Therapeutics FY 2025 net loss rises 91% to USD 162.34 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618640703","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618640703?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:09","pubTimestamp":1773054582,"startTime":"0","endTime":"0","summary":"Dianthus reported a Q4 net loss of USD 64.43 million, compared with a year-ago loss of USD 28.44 million. Q4 R&D expenses rose 127% to USD 59.9 million. For FY 2025, net loss increased 91% to USD 162.34 million and R&D expenses rose 75% to USD 145.64 million. Cash, cash equivalents and investments totaled USD 514.4 million as of Dec. 31, 2025, and the company said this is projected to provide runway into 2028. Dianthus said it reached an early GO decision in the Phase 3 CAPTIVATE trial of claseprubart in CIDP after achieving 20 confirmed responders with less than 40 planned participants completing Part A.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL9B9Qwt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4588","IE00B3QW5Z07.USD","SG9999014021.USD","DNTH","BK4112","BK4139","LU2210150020.SGD","BK4585","SG9999014013.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","SG9999014039.USD","LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","NDAQ","LU2095319765.USD"],"gpt_icon":0},{"id":"2618164004","title":"Dianthus Therapeutics Highlights Recent Business Achievements, Including Go Decision for Phase 3 Captivate Cidp Trial, and Reports Q4 and FY 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2618164004","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618164004?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:09","pubTimestamp":1773054547,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nTUA5SVJJ3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2618640169","title":"Dianthus Therapeutics Inc - Independent Dsmb Review Confirms Go Decision; No Related Serious Infections or Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2618640169","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618640169?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:01","pubTimestamp":1773054081,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZX0UV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2618640156","title":"Dianthus Therapeutics Announces Early Go Decision Following Interim Responder Analysis in Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (Cidp)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618640156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618640156?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:01","pubTimestamp":1773054081,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZX0UV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2618640150","title":"Dianthus Therapeutics Inc - Maintains 300Mg/2Ml S.c. Q2w Dose; Plans to Remove 600Mg/4Ml S.c. Q2w Arm","url":"https://stock-news.laohu8.com/highlight/detail?id=2618640150","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618640150?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:01","pubTimestamp":1773054081,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZX0UV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2618158640","title":"Dianthus Therapeutics Inc - Expects to Provide Captivate Part B Top-Line Guidance by End of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618158640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618158640?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:01","pubTimestamp":1773054081,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZX0UV:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DNTH"],"gpt_icon":0},{"id":"2618069913","title":"Dianthus Therapeutics to Present Interim Phase 3 CAPTIVATE CIDP Trial Responder Results for Claseprubart","url":"https://stock-news.laohu8.com/highlight/detail?id=2618069913","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618069913?lang=en_us&edition=fundamental","pubTime":"2026-03-09 05:00","pubTimestamp":1773003618,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc. announced it will host a conference call and webcast on March 9, 2026 at 8:00 a.m. ET to discuss interim responder analysis results from Part A of the Phase 3 CAPTIVATE trial evaluating claseprubart in chronic inflammatory demyelinating polyneuropathy. The company said the results have not yet been presented and will be discussed during the scheduled event.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260308:nNDL5LHQwG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4112","SG9999014005.SGD","IE00B64PRP62.GBP","LU0314104364.USD","LU2095319765.USD","LU2210149790.SGD","BK4588","NDAQ","IE00B3QW5Z07.USD","SG9999014013.SGD","DNTH","IE00BKPKM429.USD","SG9999014021.USD","BK4585","LU2210150020.SGD","IE00BGHQF748.EUR","BK4139"],"gpt_icon":0},{"id":"2616553059","title":"Dianthus price target raised to $200 from $100 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2616553059","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616553059?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:34","pubTimestamp":1772627645,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Dianthus (DNTH) to $200 from $100 and keeps a Buy rating on the shares. Following adjustments to the f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dianthus-price-target-raised-to-200-from-100-at-guggenheim-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dianthus-price-target-raised-to-200-from-100-at-guggenheim-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2616374442","title":"BRIEF-Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616374442","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616374442?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:32","pubTimestamp":1772573561,"startTime":"0","endTime":"0","summary":"BRIEF-Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)March 3 (Reuters) - Dianthus Therapeutics Inc DNTH.O:DIANTHUS THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nTUA4FLCPF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","BK4139"],"gpt_icon":0},{"id":"2616716003","title":"Dianthus Therapeutics Grants 26,000 Inducement Stock Options to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2616716003","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616716003?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:01","pubTimestamp":1772571673,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc. granted inducement equity awards to three newly hired, non-executive employees, consisting of non-qualified stock options covering a total of 26,000 common shares. The options have a 10-year term, an exercise price of $55.26 per share, and vest 25% after one year with the remainder vesting in equal monthly installments over the next 36 months.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL3SPq9K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014021.USD","LU2095319765.USD","LU0314104364.USD","LU2210149790.SGD","IE00BKPKM429.USD","BK4112","DNTH","NDAQ","BK4139","SG9999014013.SGD","LU2210150020.SGD","SG9999014039.USD","BK4588","BK4585"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":71,"code":"91000000","status":"200"}]}}